No Data
No Data
Tibet Aim Pharm. Inc.: 2024 Interim Performance Forecast
As of July 10th, tibet aim pharm. inc. (002826.SZ) has 18,428 shareholders.
On July 12th, Gelonhui reported that Tibet Aim Pharm. Inc. (002826.SZ) stated on the investor interaction platform that, according to the shareholder registry issued by China Securities Depository and Clearing Corporation's Shenzhen Branch, as of July 10th, 2024, the number of shareholders in the company is 18,428.
Tibet Aim Pharm. Inc. (002826.SZ) announced a profit increase and expects a net income of 31.53 million to 45.32 million yuan for the first half of the year, a growth of 123.92% to 221.86%.
Tibet Aim Pharm. Inc. (002826.SZ) released its performance forecast for the first half of 2024, and the company expects a net profit attributable to the reporting period...
Tibet Aim Pharm. Inc. (002826.SZ): Has repurchased 3.778% of shares.
Tibet Aim Pharm. Inc. (002826.SZ) announced that as of June 30, 2024, the company has repurchased a total of 7,203,800 shares through a share repurchase dedicated securities account using centralized competitive trading, accounting for 3.7780% of the company's current total share capital. The highest fill price was 8.96 yuan/share, and the lowest fill price was 5.84 yuan/share. The total amount of repurchases was 50,000,570 yuan (excluding transaction costs).
As of June 28th, tibet aim pharm. inc. had 18,773 shareholders.
On July 2nd, Gelonhui reported that Tibet AIM Pharm. Inc. (002826.SZ) stated on the investor interaction platform that, according to the latest shareholder list issued by China Securities Depository and Clearing Corporation Shenzhen Branch, as of June 28, 2024, the company has 18,773 shareholders.
As of June 20, 2024, there were 18,938 shareholders in Tibet AIM Pharm. Inc. (002826.SZ).
As of June 20, 2024, tibet aim pharm. inc. had 18,938 shareholders, according to a statement on the investor interaction platform.
No Data